Brinton Pharma makes Covid treatment manageable by launching 400 mg tablets at Rs 79... Aug 21
Cipla receives regulatory approval for launch of Ciplenza (Favipiravir 200 mg) in India to treat mild to moderate COVID-19... Jul 27
Cipla and Brinton Pharmaceutical's cheap Favipiravir to hit the market soon... Jul 24
Pune based Brinton Pharmaceutical gets DGCI nod for Favipiravir... Jul 24
-Advertisements-